Healthcare / Medical Care FacilitiesNZSE
$5.00
+0.20 (+4.17%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $2.5M · quality 71.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
57/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$50M
P/E
21.7x
↑EV/EBITDA
11.3x
↓ROE
60.9%
↑Gross Margin
51.9%
↑Debt/Equity
0.93
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+47.9%
FCF CAGR
+49.6%
FCF margin
18.6%
FCF / Net income
1.52x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $19.1M · net income $2.3M · FCF $3.5M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $19.1M | $19.1M | $15.2M | $11.2M | $5.9M |
| Net Income | $2.3M | $2.3M | $1.4M | $438000.00 | $1.2M |
| EBITDA | $4.5M | $4.5M | $3.0M | $1.6M | $1.7M |
| EPS | — | — | 0.14 | 0.04 | 0.12 |
| Gross Margin | 51.9% | 51.9% | 50.3% | 53.9% | 62.6% |
| Operating Margin | 19.8% | 19.8% | 14.8% | 8.7% | 26.3% |
| Net Margin | 12.3% | 12.3% | 9.1% | 3.9% | 19.9% |
| Balance Sheet | |||||
| Debt/Equity | 0.93 | 0.93 | 1.42 | 2.09 | 0.40 |
| Current Ratio | 1.05 | 1.05 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $3.5M | $3.5M | $2.5M | $1.0M | $1.1M |
| Returns | |||||
| ROE | 60.9% | 60.9% | 48.4% | 17.0% | 43.5% |
| Valuation | |||||
| P/E | 21.74 | 21.74 | 12.45 | 36.53 | 23.31 |
| EV/EBITDA | 11.30 | 11.30 | 6.57 | 12.85 | 15.82 |
| P/B | 12.95 | 12.95 | 6.04 | 6.22 | 10.14 |
| Growth & Yield | |||||
| Revenue Growth | 25.9% | 25.9% | 35.1% | 90.1% | — |
| EPS Growth | — | — | 215.3% | -62.9% | — |
| Dividend Yield | 3.3% | 3.3% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+57.2%
Start / end P/E
n/dx → n/dx
EPS bridge
0.14 → n/d
Residual
+53.8%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.